Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer.
Jared DeckMarissa HartleyMohammad AkhterDongliang WangJeffrey A BogartMichael D MixPublished in: Lung Cancer (Auckland, N.Z.) (2023)
In this cohort of patients with stage III NSCLC, baseline hematologic factors were associated with clinical outcomes including baseline ALC, baseline SII and recovery ALC. Disease response was not well correlated with hematologic factors or clinical outcomes.